Bond AbbVie Inc. 2.95% ( US00287YBV02 ) in USD
| Issuer | AbbVie Inc. | 
| Market price | |
| Country |       United States
                         | 
                     
| ISIN code | 
                          US00287YBV02 ( in USD )
                         | 
                     
| Interest rate | 2.95% per year ( payment 2 times a year) | 
| Maturity | 20/11/2026 | 
| 
 Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible  | 
                     |
| Minimal amount | 2 000 USD | 
| Total amount | 3 990 755 000 USD | 
| Cusip | 00287YBV0 | 
| Standard & Poor's ( S&P ) rating | BBB+ ( Lower medium grade - Investment-grade ) | 
| Moody's rating | Baa2 ( Lower medium grade - Investment-grade ) | 
| Next Coupon | 21/11/2025 ( In 17 days ) | 
| Detailed description | 
                        AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. The Bond issued by AbbVie Inc. ( United States ) , in USD, with the ISIN code US00287YBV02, pays a coupon of 2.95% per year. The coupons are paid 2 times per year and the Bond maturity is 20/11/2026 The Bond issued by AbbVie Inc. ( United States ) , in USD, with the ISIN code US00287YBV02, was rated Baa2 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by AbbVie Inc. ( United States ) , in USD, with the ISIN code US00287YBV02, was rated BBB+ ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency.  | 
                     
 Français
 Italiano
  United States